A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells

scientific article published on April 2007

A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2006-07-032839
P698PubMed publication ID17119119
P5875ResearchGate publication ID6679143

P50authorStefan TenzerQ40190438
Claudine GrafQ90196799
Christoph HuberQ95028765
P2093author name stringThomas Wölfel
Cedrik M Britten
Thomas Fischer
Markus P Radsak
Florian Heidel
Fian K Solem
P433issue7
P407language of work or nameEnglishQ1860
P1104number of pages4
P304page(s)2985-2988
P577publication date2007-04-01
P1433published inBloodQ885070
P1476titleA neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells
P478volume109

Reverse relations

cites work (P2860)
Q37242561Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells
Q27006934Adoptive T-cell therapy for Leukemia
Q36662079Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation
Q37363129Clinical implications of molecular genetic aberrations in acute myeloid leukemia
Q42609684Clinically relevant doses of FLT3-kinase inhibitors quizartinib and midostaurin do not impair T-cell reactivity and function.
Q34350591FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes
Q38318484Immunogenic peptide discovery in cancer genomes.
Q38015123Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.
Q44976497Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
Q92539066Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?
Q38664735Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?
Q36652124Programmed death-1 checkpoint blockade in acute myeloid leukemia
Q38225994Regulation of hematopoietic and leukemic stem cells by the immune system.
Q37890244T-cell receptor gene therapy: critical parameters for clinical success
Q91711253The Graft-Versus-Leukemia Effect in AML

Search more.